IP Verse

Dna-Pkcs Inhibitors For Increasing Genome Editing Efficiency

Patent No. EP3911330 (titled "Dna-Pkcs Inhibitors For Increasing Genome Editing Efficiency") was filed by MAX Planck Gesellschaft ZUR Frderung DER Wissenschaften EV on Dec 19, 2019. The application was issued on Mar 5, 2025.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
MAIWALDDec 4, 2025MAIWALD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3911330

MAX PLANCK GESELLSCHAFT ZUR FRDERUNG DER WISSENSCHAFTEN EV
Application Number
EP19828736A
Filing Date
Dec 19, 2019
Status
Granted And Under Opposition
Jan 31, 2025
Publication Date
Mar 5, 2025
External Links
Slate, Register , Google Patents